Brief: Oric Pharmaceuticals Reports First Quarter 2023 Financial Results And Operational Updates

ORIC Pharmaceuticals

08/05/2023 23:28

Oric Pharmaceuticals Inc  ORIC.O :
    * ORIC PHARMACEUTICALS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND OPERATIONAL UPDATES
    * CASH AND INVESTMENTS OF $208.9 MILLION EXPECTED TO FUND
OPERATING PLAN INTO FIRST HALF OF 2025
    * EXPECT TO REPORT INITIAL PHASE 1B DATA FOR ORIC-944 IN THE
SECOND HALF OF 2023
    * EXPECT TO REPORT INITIAL PHASE 1B DATA FOR ORIC-114 IN THE
SECOND HALF OF 2023
    * EXPECT TO REPORT INITIAL PHASE 1B DATA FOR ORIC-533 IN THE
SECOND HALF OF 2023
    * QTRLY LOSS PER SHARE $0.53
    * Q1 EARNINGS PER SHARE VIEW $-0.54 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5S5lVs 
Further company coverage:  ORIC.O